Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Surbpong Tanasanvimon"'
Autor:
Sameek Roychowdhury, Teresa Macarulla, Dirk Waldschmidt, Milind Javle, Ai Li, Robin Kate Kelley, Anthony B. El-Khoueiry, Ivan Borbath, Ghassan K. Abou-Alfa, Wei Peng Yong, Lipika Goyal, Philip A. Philip, Harris S. Soifer, Mitesh J. Borad, Michael Bitzer, Surbpong Tanasanvimon, Susan Moran, Andrew X. Zhu, Tanios Bekaii-Saab, Saeed Sadeghi, Stacie Peacock Shepherd, Amit Pande, Karl Heinz Weiss
Publikováno v:
The lancet. Gastroenterologyhepatology. 6(10)
Summary Background Treatment options are sparse for patients with advanced cholangiocarcinoma after progression on first-line gemcitabine-based therapy. FGFR2 fusions or rearrangements occur in 10–16% of patients with intrahepatic cholangiocarcinom
Autor:
Kessarin Thanapirom, Prapimphan Aumpansub, Panarat Thaimai, Surbpong Tanasanvimon, Pattana Angspatt, Yuwadee Ponauthai, Sirinporn Suksawatamnuay, Yong Poovorawan, Piyawat Komolmit, Satimai Aniwan, Sakolkan Sumbin
Publikováno v:
Gastroenterology. 150:S888
Autor:
Surbpong Tanasanvimon, Yong Poovorawan, Pattana Angspatt, Sumitra Wiangngoen, Piyawat Komolmit, Patchneeya Wiriyapongpattana, Prapimphan Aumpansub, Sirinporn Suksawatamnuay, Yuwadee Ponauthai, Satimai Aniwan, Kessarin Thanapirom, Panarat Thaimai
Publikováno v:
Gastroenterology. 150:S888